News | July 07, 2014

Corindus Robotics Receives Frost & Sullivan 2014 New Product Innovation Award in Interventional Cardiology

CorPath is first and only FDA-cleared robotic system for percutaneous coronary intervention (PCI)

June 7, 2014 — Corindus Vascular Robotics has been named the recipient of the 2014 North American New Product Innovation Award in Interventional Cardiology, which was established by Frost & Sullivan to recognize visionary innovation and product excellence. Corindus’s CorPath vascular robotic system is the first medical device to bring robotic precision and accuracy to coronary angioplasty procedures, which may improve clinical outcomes while increasing radiation protection for interventional cardiologists.

“To achieve excellence in new product innovation leadership is not an easy task, but the CorPath system addresses a critical concern of interventional cardiologists, and has the potential to improve outcomes and economics in coronary angioplasty,” said Greg Caressi, senior vice president, Healthcare & Life Sciences, Frost & Sullivan. “Corindus’s receipt of this award signifies a great accomplishment.”

The CorPath System stood out from other products in the market with differentiators such as:

  • Fulfilling Unmet Needs in Interventional Cardiology. The CorPath system provides tremendous benefits that decrease key career-limiting issues that physicians tend to face as a result of radiation exposure.
  • Optimized Design Considerations for Cath Lab Use. The system was designed to have the physician sitting in the interventional cockpit, removed from radiation, in a robotic control unit that sits beside the patient on the patient table bedrail.
  • Advancing Care and Safety. It can safely navigate through the vascular anatomy to perform balloon stenting techniques.
  • Innovative CorPath One Stent Program. Corindus Vascular Robotics launched the “CorPath One Stent Program” to highlight the precision and accuracy of the system by offering a $1,000 credit to hospitals that use two or more stents per lesion in coronary angioplasties performed with CorPath.
  • Future Promise. The CorPath system is believed to have a future in emerging interventional techniques and could be leveraged for procedures in other related fields.


For more information:,

Related Content

Corindus CorPath GRX Used in Live Complex Robotic-Assisted Coronary Intervention at EuroPCR 2019
News | Robotic Systems | May 28, 2019
Corindus Vascular Robotics Inc. announced its CorPath GRX System was successfully used to perform a live complex...
Stereotaxis Announces Next-generation Robotic Magnetic Navigation and Imaging Systems

Robotic electrophysiology operating room including Stereotaxis Genesis RMN and Stereotaxis Imaging Model S systems. Image courtesy of Stereotaxis.

News | Robotic Systems | May 09, 2019
Stereotaxis introduced Stereotaxis Genesis RMN, its next-generation robotic platform that it claims is a significant...
Corindus CorPath Used in World's First-in-Human Telerobotic Coronary Intervention
News | Robotic Systems | December 06, 2018
Corindus Vascular Robotics Inc. announced that its CorPath technology was used to conduct the first-in-human (FIH)...
Corindus Announces First Live Transmission of Remote Robotic Demonstration at TCT 2018
News | Robotic Systems | September 24, 2018
Corindus Vascular Robotics Inc. announced the first live transmission of a remote interventional procedure using the...
Corindus and Mayo Clinic Conducting Preclinical Telestenting Study of Remote PCI Capabilities
News | Robotic Systems | January 08, 2018
Corindus Vascular Robotics Inc. announced that it is working with Mayo Clinic in a preclinical study about use of...
Corindus and Houston Methodist DeBakey Heart & Vascular Center Launch Robotic Training Site
News | Robotic Systems | December 28, 2017
Corindus Vascular Robotics Inc. announced recently that Houston Methodist DeBakey Heart & Vascular Center has...
Robocath Receives $1.5 Million in Capital for Advancement of R-One Robotic System
News | Robotic Systems | December 06, 2017
December 6, 2017 — French company Robocath, which designs and develops...
Montreal Heart Institute Performs First Robotic Mitral Valve Surgery
News | Robotic Systems | September 22, 2017
The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems | September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Large Multicenter Study Shows High Success Rate for Robotic PCI Procedures, SCAI, Corindus CorPath 200
News | Robotic Systems | May 16, 2017
The largest real-world study of robotic percutaneous coronary intervention (PCI) demonstrated clinical and technical...
Overlay Init